Combinatorial complexity of 5′ alternative acetylcholinesterase transcripts and protein products

被引:97
作者
Meshorer, E
Toiber, D
Zurel, D
Sahly, I
Dori, A
Cagnano, E
Schreiber, L
Grisaru, D
Tronche, F
Soreq, H [1 ]
机构
[1] Hebrew Univ Jerusalem, Inst Life Sci, Dept Biol Chem, IL-91904 Jerusalem, Israel
[2] Hebrew Univ Jerusalem, Inst Life Sci, Israel Ctr Neuronal Computat, IL-91904 Jerusalem, Israel
[3] Coll France, Inst Biol, CNRS FRE2401, F-75231 Paris 5, France
[4] Soroka Univ Med Ctr, Dept Pathol, IL-64239 Tel Aviv, Israel
[5] Tel Aviv Univ, Sourasky Med Ctr, Dept Pathol, IL-84105 Tel Aviv, Israel
[6] Tel Aviv Univ, Sourasky Med Ctr, Dept Obstet & Gynecol, IL-84105 Tel Aviv, Israel
关键词
D O I
10.1074/jbc.M402752200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
To explore the scope and significance of alternate promoter usage and its putative inter-relationship to alternative splicing, we searched expression sequence tags for the 5' region of acetylcholinesterase ( ACHE) genes. Three and five novel first exons were identified in human and mouse ACHE genes, respectively. Reverse transcription-PCR and in situ hybridization validated most of the predicted transcripts, and sequence analyses of the corresponding genomic DNA regions suggest evolutionarily conserved promoters for each of the novel exons identified. Distinct tissue specificity and stress-related expression patterns of these exons predict combinatorial complexity with known 3' alternative AChE mRNA transcripts. Unexpectedly one of the 5' exons encodes an extended N terminus in-frame with the known AChE sequence, extending the increased complexity to the protein level. The resultant membrane variant(s), designated N-AChE, is developmentally regulated in human brain neurons and blood mononuclear cells. Alternative promoter usage combined with alternative splicing may thus lead to stress-dependent combinatorial complexity of AChE mRNA transcripts and their protein products.
引用
收藏
页码:29740 / 29751
页数:12
相关论文
共 40 条
[1]   Novel messenger RNA and alternative promoter for murine acetylcholinesterase [J].
Atanasova, E ;
Chiappa, S ;
Wieben, E ;
Brimijoin, S .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (30) :21078-21084
[2]   Alu repeats and human genomic diversity [J].
Batzer, MA ;
Deininger, PL .
NATURE REVIEWS GENETICS, 2002, 3 (05) :370-379
[3]   The C-terminal T peptide of acetylcholinesterase enhances degradation of unassembled active subunits through the ERAD pathway [J].
Belbeoc'h, S ;
Massoulié, J ;
Bon, S .
EMBO JOURNAL, 2003, 22 (14) :3536-3545
[4]  
Ben Aziz-Aloya R, 1993, Prog Brain Res, V98, P147
[5]   The role of readthrough acetylcholinesterase in the pathophysiology of myasthenia gravis [J].
Brenner, T ;
Hamra-Amitay, Y ;
Evron, T ;
Boneva, N ;
Seidman, S ;
Soreq, H .
FASEB JOURNAL, 2003, 17 (02) :214-222
[6]   COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: Cloning, structure, and expression [J].
Chandrasekharan, NV ;
Dai, H ;
Roos, KLT ;
Evanson, NK ;
Tomsik, J ;
Elton, TS ;
Simmons, DL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (21) :13926-13931
[7]   Functional association between promoter structure and transcript alternative splicing [J].
Cramer, P ;
Pesce, CG ;
Baralle, FE ;
Kornblihtt, AR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (21) :11456-11460
[8]   Long-lasting acetylcholinesterase splice variations in anticholinesterase-treated Alzheimer's disease patients [J].
Darreh-Shori, T ;
Hellström-Lindahl, E ;
Flores-Flores, C ;
Guan, ZZ ;
Soreq, H ;
Nordberg, A .
JOURNAL OF NEUROCHEMISTRY, 2004, 88 (05) :1102-1113
[9]   Characterization of the expression of MHC proteins in human embryonic stem cells [J].
Drukker, M ;
Katz, G ;
Urbach, A ;
Schuldiner, M ;
Markel, G ;
Itskovitz-Eldor, J ;
Reubinoff, B ;
Mandelboim, O ;
Benvenisty, N .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (15) :9864-9869
[10]   Alternative splicing: increasing diversity in the proteomic world [J].
Graveley, BR .
TRENDS IN GENETICS, 2001, 17 (02) :100-107